pubmed-article:18036392 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0237939 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0071097 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C0289313 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:18036392 | lifeskim:mentions | umls-concept:C1875307 | lld:lifeskim |
pubmed-article:18036392 | pubmed:issue | 6 Pt 1 | lld:pubmed |
pubmed-article:18036392 | pubmed:dateCreated | 2007-11-26 | lld:pubmed |
pubmed-article:18036392 | pubmed:abstractText | Outcomes in patients with type 2 diabetes mellitus (DM) can differ based on the antidiabetic medication that is used. Thiazolidinediones (TZDs) are a newer class of agents used for the treatment of type 2 DM. No previous study has compared health care utilization associated with the 2 TZDs on the market. | lld:pubmed |
pubmed-article:18036392 | pubmed:language | eng | lld:pubmed |
pubmed-article:18036392 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18036392 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18036392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18036392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18036392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18036392 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18036392 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18036392 | pubmed:month | Jun | lld:pubmed |
pubmed-article:18036392 | pubmed:issn | 1879-114X | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:BalkrishnanRa... | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:ArondekarBhak... | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:AndersonRoger... | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:CamachoFabian... | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:ShenolikarRah... | lld:pubmed |
pubmed-article:18036392 | pubmed:author | pubmed-author:HorblyukRusla... | lld:pubmed |
pubmed-article:18036392 | pubmed:copyrightInfo | (c) 2007 Excerpta Medica, Inc. | lld:pubmed |
pubmed-article:18036392 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18036392 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:18036392 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18036392 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18036392 | pubmed:pagination | 1306-15 | lld:pubmed |
pubmed-article:18036392 | pubmed:dateRevised | 2009-9-18 | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:meshHeading | pubmed-meshheading:18036392... | lld:pubmed |
pubmed-article:18036392 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:18036392 | pubmed:articleTitle | Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus. | lld:pubmed |
pubmed-article:18036392 | pubmed:affiliation | Department of Pharmacy Practice and Administration, The Ohio State University, Columbus, Ohio 43210, USA. balkrishnan.l@osu.edu | lld:pubmed |
pubmed-article:18036392 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18036392 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:18036392 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |